Ixiaro FDA Approval History
FDA Approved: Yes (First approved March 30, 2009)
Brand name: Ixiaro
Generic name: Japanese Encephalitis Virus Vaccine, Inactivated, Adsorbed
Company: Intercell AG
Treatment for: Japanese Encephalitis Virus Prophylaxis
Ixiaro (Japanese Encephalitis Virus Vaccine, Inactivated, Adsorbed) is a purified, inactivated product for active immunization against viral infections of Japanese Encephalitis.
Development timeline for Ixiaro
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.